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Abstract 
Objectives: The study aim was to explore the knowledge, perceptions, and attitudes of Iraqi physicians regarding generic and locally 
manufactured medicines. 
Methods: A total of 124 physicians were involved in this cross -sectional study. The convenience sample was collected from five public 
hospitals in Baghdad. A self-administered questionnaire was distributed and collected in-person. Fisher's Exact Test was used to 
measure the association between physician years of experience, gender and categorical (perception and knowledge) variables. 
Results: Most respondent answers regarding the knowledge of generic medicines were incorrect. Only up to one-third of the 
participants knew that generic medicines are therapeutically equivalent to brand name medicines (26.6%), as safe as brand name 
medicines (34.7%) and required to meet similar safety standards as brand name medicines (12.1%). With respect to perception, many 
physicians had negative perceptions about generic medicines such as viewing generic medicines as lower quality (57.3%) and cause 
more side effects (41.1%) compared to brand name medicines. Regarding physician attitudes toward generic medicines, about two-
thirds (64.5%) of the physicians were willing to prescribe low cost medicines; however, only about half (51.6%) of the physicians 
reported they offer generic medicines to their patients. Finally, 64.5% of the participants were not comfortable with pharmacist 
replacing prescribed brand with generic medicines.  
Conclusions: In general, Iraqi physicians have negative perceptions and attitudes about generic and locally manufactured medicines. 
Significant gaps were identified in the knowledge and perceptions among physicians regarding generic medicines especially in relation 
to efficacy and safety of generic medicines. 
 
Keywords: Physicians, knowledge, attitude, perceptions, generic medicines  
 
 
Introduction  
The US Food and Drug Administration (FDA) defines generic 
medicines as a medication that is comparable to brand listed 
medication in dosage form, strength, route of administration, 
quality and performance characteristics, and intended use (1). 
A brand-name drug is a drug that has a trade name and is 
protected by a patent. When the patent protection of a brand-
name drug expires, generic versions of the drug can be offered 
for sale (2). A generic drug is a proven bioequivalent to the 
innovator brand, where both deliver the active ingredient to 
the blood stream at the same rate and to the same extent (3).  
Under the FDA’s regulations, a generic medicine must contain 
identical amount of the same active ingredients in the same 
dosage form as a brand name medicine (4).  
 
Generic medicines are generally less expensive than their 
brand-name counterparts. Generic drugs typically cost 30% to 
60% less than their brand-name counterparts (5).  Global 
healthcare expenditure is increasing steadily, and generic  
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medicine utilization is often encouraged as a cost-containment 
measure (5)(6). In addition, patients taking generic drugs 
appear to be more compliant than those taking brand-name 
medications. Lower copayment is a key factor (7). Many doctors 
oppose brand substitution and believe generic medicines to be 
inferior to their branded counterparts (8).  Physician 
perceptions about generic drugs may affect their acceptance of 
generic drugs. According to a recent systematic review, about 
one-quarter of physicians and pharmacists expressed negative 
perceptions about the safety and side effects of generic 
medicines (8). In the UK, there was strong opposition when 
plans were proposed to introduce generic substitution into UK 
primary care (9).   
 
As the main prescribers of medicines in Iraqi healthcare 
settings, physicians have an essential role in recommending 
generic medicines for patients. Generally, Iraqi private 
healthcare settings do not implement health insurance and 
patients should pay physician visit fees and medication costs 
out of pocket. At present, there is no reimbursement system 
for money spent by the public on prescriptions from 
community pharmacies in the country. Many families with 
limited income cannot afford the cost of brand name 
medicines. Thus, ensuring the availability of high-quality 
medicines at affordable prices in Iraq is a public health priority 
(10). 
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To the best of our knowledge, this was the first study 
quantitatively assessed physician knowledge, perceptions and 
attitudes toward generic medicines. The aim of the current 
study was to explore the knowledge, perceptions, and 
attitudes of physicians regarding generic and locally 
manufactured medicines in Baghdad. 
 
Methods 
Design and Settings: This was a cross sectional study carried out 
during the four months from April to August 2019. The 
convenience sample was collected from five public hospitals 
across Baghdad and its suburb (Baghdad Teaching Hospital, Al-
Yarmouk Teaching Hospital, Al-Numan Teaching Hospital, Ibn 
Al-Baitar Teaching Hospital and Abu Ghraib Hospital) which 
represent the main hospitals in both sides of the province.  
 
Participants: Physicians from all specialties were included if 
they had a private clinic and were willing to participate in the 
study. The study selected physicians practicing in private clinic 
because physicians in the private sector (clinics) have more 
prescribing choices and flexibility compared to the public 
(governmental) sector. The study included physicians working 
at morning shift from any specialties who had a private clinic 
and agreed to participate. After obtaining the consent from the 
physicians, a paper self-administered questionnaire was 
distributed and collected in-person.  
 
Survey: We adopted the survey items from Jamshed et al, 2012 
study (11). Thus, the survey items were already validated. The 
questionnaire consisted of four parts. The first part included 
sociodemographic of the participating physicians. The second 
part included 12 statements and addressed the physician 
knowledge about interchangeability, safety, quality and 
efficacy of generic medicines.  The third part included 14 
statements and addressed the physician perceptions about 
safety, quality and efficacy of generic medicines. The fourth 
part included 12 statements and evaluated the attitude of 
physicians towards generic medicine prescribing considering 
the socioeconomic condition of the patient, patients’ demands, 
and influence of medical representatives. Knowledge domains 
have response categories of yes/no. Perception and attitude 
domains have response categories on Likert scale: 3=Agree, 
2=Neutral, 1=Disagree (11). 
 
Ethical approval:  The study proposal was approved by the 
Ethical and Scientific committee at University of Baghdad 
College of Pharmacy.  
 
Statistical analysis 
The analyses were conducted using the Statistical Package for 
the Social Science (SPSS, version 22, IBM, New York, USA). 
Descriptive statistics (means, standards deviations, frequencies 
and percentages) of the participants were calculated. Fisher's 
Exact Test was used to measure the association between 
physician years of experience and gender from one side and 
perception and knowledge variables from other side. The 
answers for knowledge questions were yes, no, I do not know. 
“I do not know’ answers were also considered incorrect as a 
previous study conducted in the Netherlands (12). Perception 
and attitude questions had 3-points Likert scale answers 
(disagree, neutral, agree). A p-value < 0.05 was considered 
statistically significant. 
 
Results  
A total of 124 physicians (85 male and 39 female) were 
involved in this study. The age range of physicians was 28-62 
years with a mean of 39.2± 6.1 years. The demographics and 
professional characteristics of the participating physicians are 
shown in table 1. When the respondents were asked about the 
basic information regarding generic medicines, the majority 
gave incorrect answers for nine out of 12 questions (Table 2 
and Figure 1).  
 
Fisher's Exact test showed that there was no significant 
difference (p-value > 0.05) in physicians’ knowledge (correct vs 
incorrect answers) according to their gender (Table 2). The 
Fisher's Exact test also measured the difference in physician 
knowledge according to their years of experience. Two 
knowledge items were significantly different across years of 
physician experience. The elder generation physicians (with 
more than 5 years of experience) had significantly more 
incorrect answers about brand name medicines having fewer 
side effects and meeting higher safety measures compared to 
younger generation physicians (with less than 5 years of 
experience) (Table 2). 
 
Most physicians had negative perceptions about generic 
medicines such as viewing generic medicines of low quality 
than brand name medicines (57.3%) and thinking that they 
produce more side effects than brand name medicines (41.1%) 
(Table 3). Most physicians (87.9%) believed that they should 
be educated more about prices of medicines. In addition, more 
than half (54.8%) perceived that low-cost medicines are not 
safe as high-priced medicines and 54.0% believed that it is 
easier to remember a brand name medicine. Regarding gender 
difference, significantly more male physicians agreed (n=62, 
72.9%) compared to female that local companies are not 
following GMP guideline (table 3). Regarding years of 
experience, significantly more elder generation physicians 
(with more than 10 years of experience) believed that generic 
medicines produce more side effects than brand name 
medicines (Table 3). 
 
A total of 12 questions were used to investigate the attitude 
of participating physicians towards generic medicines (Table 
4). Although two-thirds (64.5%) of the physicians were willing 
to prescribe low cost medicines, only half (51.6%) reported 
they offer generic medicines to their patients. More than half 
(58.9%) of the physicians were hesitant to prescribe low-cost 
medicines. Additionally, two-thirds (64.5%) were not 
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comfortable with the pharmacist replacing prescribed brands 
with generic medicines (Table 4). On the other hand, no 
significant difference (p-value > 0.05) in physicians’ attitudes 
according to their gender.  
 
According to the years of experience, the elder generation 
physicians (with more than 10 years of experience) were 
significantly less affected by socioeconomic status of patients 
when prescribe medications compared to physicians with ≤10 
years of experience. Similarly, the prescribing of physicians 
with experience longer than 10 years were significantly less 
affected by patient’s demand (Table 4). 
 
On the other hand, most physicians had negative perceptions 
and attitudes toward locally manufactured medicines (Figure 
2). They believed that local medicines are less effective and 
have lower quality compared to brand medicines. Thus, they 
prescribe brand medicines for most cases. However, the 
majority physicians agreed that local medicines are more 
affordable than brand name ones (Figure 2).  
 
Discussion 
According to the study findings, there were gaps in the 
physician knowledge of generic medicines. Incorrect 
information was common among physicians about the safety, 
efficacy and quality of generic medicines. Out of 12 questions 
evaluating the knowledge of generic medicines, nine questions 
were answered incorrectly by the majority of physicians (Table 
2 and Figure 1). The only three items that were answered 
correctly included that generic medicines are interchangeable 
with brand name medicines, generic medicines must be in the 
same dosage forms as brand medicines, and generic medicines 
are available in Iraq. These findings indicated a lack of 
physician knowledge about generic medicines which may have 
a negative impact on the confidence in generic drugs and 
consequently their prescribing. Cultural belief of low-cost 
products usually are less quality and effectiveness may also 
influence physician negative perceptions of generic medicines. 
Thus, the majority perceived that brand medicines are more 
effective and meet higher safety measures.  This inadequate 
knowledge among physicians in the current study may be 
related to their coursework at Colleges of Medicines which did 
not adequately cover the topic of generic medicines in their 
curriculum. This reason was also reported by a previous study 
among final year medical students in Iraqi universities (4). 
 
Similarly, Fabianio and colleagues found only 32.6% and 37.2% 
of Italian pediatricians have adequate and good knowledge of 
generic medicines respectively (13). In addition, only 2.3% to 
4.6% of physicians in Malaysia correctly identified 
bioequivalence standards for generic medicines in recent 
studies (14)(15).  In contrast, a study among general 
practitioners in Pakistan found that 71.8% of respondents had 
the correct definitions (11).  
 
The elder generation physicians (with more than 5 years of 
experience) had significantly more incorrect answers about 
brand medicines to have fewer side effects and meet higher 
safety measures compared to younger generation physicians 
(with less than 5 years of experience). In contrast, a study 
among general practitioners in Nigeria found that 63.7% of 
respondents had at least average knowledge about the 
concept of generic medicine.  Nigerian physicians with more 
than 10 years post-graduation experience have a higher 
knowledge mean score (16).  
 
Regarding perceptions about generic medicines, most 
physicians had negative perceptions such as viewing generic 
medicines as lower quality and producing more side effects 
than brand name medicines.  These negative physician 
perceptions may be because Iraqi pharmaceutical market 
contains so many generic drug products from wide range of 
countries (such as India, China, Turkey and Arabic countries) 
and some of these products are not officially registered and 
tested by Iraqi Ministry of Health (MOH). At the same time 
brand name medicines (from the U.S. and Europe) are also 
available in Iraqi drug market. Although brand name medicines 
are costly for Iraqi patients who pay out-of-pocket, physicians 
still prefer to prescribe well-known branded medicines.  
Colgan and colleagues conducted a systematic review of 52 
articles about perceptions of generic medications among 
general population, doctors and pharmacists (8). The review 
found that a significant proportion of doctors hold negative 
perceptions of generic medicines such as generics as less 
effective, less safe, inferior in quality and more likely to cause 
side effects compared to their brand equivalents. More than a 
quarter of doctors believed that generic drugs are less 
effective and of poorer quality than brand name medications. 
A similar proportion of doctors had safety concerns about 
generics (8).  
 
These findings are important as previous work has suggested 
that negative perceptions about generic medicines are major 
barriers to their acceptance and widespread usage (17). One 
of the interesting findings in our study was 87.9% of 
respondents agreed that doctors should be educated about 
the costs of medicine. Thus, we endorsed the suggestions of 
Cooke and colleagues, which highlighted the significance of a 
basic understanding of healthcare financing and cost-
consciousness among future medical practitioners (18).  
 
The current study showed that older generation physicians 
(with more than 10 years of experience) were more likely to 
believe that generic medicines produce more side effects than 
brand medicines. These beliefs may be because younger 
physicians trained in an atmosphere where generics are used 
at increasing rates or may be related to perceptions of 
improved generic manufacturing processes (19). Similarly, an 
American study found that physicians older than 55 years of 
age have more than three times the negative perceptions to 
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generics as younger doctors (19). The youngest physicians 
(under the age of 35) were significantly less likely to hold 
negative views regarding the quality and more likely to report 
a personal preference for generics or to recommend them to 
their families (19).  
 
Regarding physician attitudes toward generic medicines, 
about two-thirds of the participants were not comfortable 
with pharmacist replacing prescribed brand with generic 
medicines (Table 4). Similarly, a previous Iraqi study showed 
hospital physicians only accept one-third of pharmacist 
recommendations (20). The physicians main concern about 
pharmacist replacing prescribed medicines is to dispense low 
quality generic medicines which may negatively impact patient 
clinical outcome. Thus, many physicians specify the trade 
name of their prescription items to avoid replacing with 
unknown low quality generics. 
 
On the other hand, about two-thirds of the physicians were 
willing to prescribe low cost medicines; however, only about 
half of the physicians reported they prescribe generic 
medicines to their patients. This shows inconsistency between 
physician intention and the behavior of prescribing. Again, the 
possibility of therapeutic failure is a major concern among 
physicians about prescribing generic medicines. Before 
approving by Iraqi MOH, generic medicines must undergo a 
rigorous registration process to ensure the quality, safety, 
efficacy and bioequivalence (21). Generally, there is a delay in 
registration process in MOH. Similarly, a Nigerian study found 
that 82.7% of physicians are worried about the possibility of 
treatment failure and 74.9% would hesitate to prescribe 
generics from certain therapeutic classes (16). The issue of 
therapeutic failure is directly related to that of bioequivalence 
(22)(23). In a Moroccan study, 70% of respondents would 
prescribe generic drugs if bioequivalence to branded 
medicines is ascertained (24). 
 
In the current study, 10.5% of respondents admitted their 
prescribing practices are influenced by gifts from 
pharmaceutical companies and 34.7% believed medical 
representatives were a good source of information. Accepting 
gifts and medical representatives may cause bias in selecting 
certain types of generic medicines over others. Providing gifts 
to doctors is common nowadays in private sector which can 
raise ethical concern and causes unfair competition between 
pharmaceutical companies. Similarly, a study among 
pharmacists and prescribers in Slovenia found only 15.5% of 
physicians admitted their prescribing behavior is influenced by 
pharmaceutical representatives (25). On the other hand, a 
Pakistani study found that 68% to 86% of the surveyed 
physicians obtained their knowledge of medicines from 
medical representatives (26).  
 
In addition, most of the physicians (especially those with ≤10 
years of experience) agreed that patient socioeconomic status 
and patient demand influence their prescribing behavior 
(Table 4). Medications from the public (governmental) sector 
are mostly subsidized or free of charge, while in community 
pharmacies (private sector), patients pay out-of- pocket 
because health insurance is not common in Iraq (27). Some 
prescriptions may impose financial burden on people with 
limited income. Thus, some patients may ask their physicians 
to prescribe not highly expensive brand medicines.  In the USA, 
being aware of patients with low socioeconomic status often 
influences the management plan of primary care physicians to 
fit their financial difficulties (28). Patient preferences can 
influence management decisions. For example, patients may 
prefer certain type of management despite it is unnecessary 
from an evidence basis. In a previous study, 71% of physicians 
stated that patient wishes had influenced their decision to 
admit patients to an intensive care unit (29). Similarly, general 
practitioners in Iceland were influenced by patients’ pressure 
to prescribe antibiotics for unnecessary cases (30). 
 
Iraqi physicians have similar negative perceptions toward 
locally manufactured products. The physicians consider 
national products as less effective and having lower quality 
compared to brand name medicines. The reason of these 
perceptions may be because they believe that national 
products are lacking the criteria of good manufacture products 
(GMP). These negative perceptions impact the physician 
prescriber behavior which is not in favor of national medicines 
as well (Figure 2).   
 
The study had some limitations. First, this study was 
conducted only in one governorate. Hence, the findings might 
not be possible to be generalized to the whole country. 
However, it can provide useful data for health policy makers 
to further improve the use of generic medicines by considering 
the physicians' perspectives. 
 
Conclusions 
In general, Iraqi physicians have negative perceptions and 
attitudes about generic and locally manufactured medicines. 
The physicians with greater clinical experience had more 
negative perception and attitudes towards the safety and 
efficacy of the generic medicine locally made in Iraq. Thus, 
awareness campaign would be needed to expand physician 
knowledge about generic medicines. 
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Table 1: The demographics and professional characteristics of the physicians 
Item Subcategory Frequency 
(N) 
% 
Gender 
Male 85 68.5 
Female 39 31.5 
Experience Years 
1-5 27 21.8 
5-10 47 37.9 
> 10 50 40.3 
Credential 
GP 28 22.6 
Specialist 82 66.1 
Consultant 14 11.3 
Specialty  
GP 28 22.6 
Cardiologist 32 25.8 
Gastroenterologist 11 8.9 
Dermatologist 3 2.4 
Gynecologist 10 8.1 
Pediatrician 7 5.6 
Internal Medicine 33 26.6 
Item Minimum Maximum Mean Std. Deviation 
Age 28 62 39.2 6.1 
Number of patients seen/day 3 40 10.2 6.2 
Medical representative visits/week 0 20 3.4 3.3 
GP=general practitioner 
 
 
 
 
 
 
Figure 1: Selected knowledge items with majority of incorrect answers 
              Brands=brand name medicines; Generics=generic medicines. 
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⁑ Experience: 3 categories :(1-5), (6-10), (>10) years. 
*Significant (P-value <0.05) according to Fisher's Exact Test. The answers for these questions were:  
   yes, no, I do not know. “I do not know’ answers were considered incorrect. 
  
 
Table 2: The knowledge of generic medicines among physicians 
Fisher's Exact Test 
(P-value) 
N (%) 
  
Experience⁑ 
Gender 
 
Incorrect 
Responses 
Correct 
Responses 
 
Knowledge item  
0.299 0.816 84 (67.7) 40 (32.3) Generic medicines are copy of brand name medicines 1 
0.377 0.982 38 (30.6) 86 (69.4) 
Generic medicines are interchangeable with brand 
name medicines 
2 
0.190 0.652 79 (63.7) 45 (36.3) 
Generic medicines are manufactured after the patent 
expiry of originator/innovator 
3 
0.754 0.166 91 (73.4) 33 (26.6) 
Generic medicines are therapeutically equivalent to 
brand name medicines 
4 
0.123 0.138 87 (70.2) 37 (29.8) 
Low-priced medicines are as effective as high-priced 
medicines 
5 
0.559 0.581 105 (84.7) 19 (15.3) 
Brand name medicines are better quality than generic 
medicines 
6 
0.270 0.615 38 (30.6) 86 (69.4) 
Generic medicines must be in the same dosage form 
(such as tablet, capsule) as brand name medicines 
7 
0.002* 0.617 109 (87.9) 15 (12.1) 
Brand name medicines are required to meet higher 
safety standards than generic medicine 
8 
0.009* 0.960 78 (62.9) 46 (37.1) 
Brand name medicines produce lesser side effects than 
generic medicines 
9 
0.127 0.338 81 (65.3) 43 (34.7) 
Generic medicines are less safe than brand name 
medicines 
10 
0.502 0.536 81 (65.3) 43 (34.7) 
Only those generic medicines are safe which are made 
by some local reputable manufacturers 
11 
0.394 0.264 17 (13.7) 107 (86.3) Generic medicines are available in the market of Iraq 12 
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Table 3: The perceptions of participating physicians about generic medicines 
 
N (%) Fisher's Exact Test 
(P-value) 
Perception item 
Disagree Neutral Agree Gender  
 
Experience⁑ 
1 I view generic medicines of low quality than 
brand name medicines 
28 (22.6) 25 (20.2) 71 (57.3) 0.867 0.931 
2 I think generic medicines produce more side 
effects than brand name medicines 
49 (39.5) 24 (19.4) 51 (41.1) 0.197 0.008* 
3 I believe low-cost medicines are as safe as 
high-priced medicines 
68 (54.8) 30 (24.2) 26 (21.0) 0.336 0.486 
4 I believe that multinational products are of 
good quality than local company products 
34 (27.4) 22 (17.7) 68 (54.8) 0.295 0.590 
5 I believe that my prescribing decision is 
influenced by medical representatives 
55 (44.4) 32 (25.8) 37 (29.8) 0.603 0.239 
6 I believe that all the local companies in Iraq 
are not following Good Manufacturing 
Practices (GMP) guidelines as multinationals 
22 (17.7) 21 (16.9) 81 (65.3) 0.016* 0.334 
7 I view few local companies as reputable 
generic medicine manufacturers 
33 (26.6) 44 (35.5) 47 (37.9) 0.179 0.501 
8 I believe that doctors should be educated 
more about prices of medicines 
8 (6.5) 7 (5.6) 109 (87.9) 0.154 0.707 
9 I believe that doctors should be given 
incentives to write generic names 
58 (46.8) 21 (16.9) 45 (36.3) 0.454 0.064 
10 I believe that generic medicines are only 
meant for poor 
65 (52.4) 27 (21.8) 32 (25.8) 0.762 0.502 
11 I think that confidence should be built in the 
patient about the low-cost medicines  
18 (14.5) 38 (30.6) 68 (54.8) 0.691 0.677 
12 I believe that it is easier to remember a brand 
name medicine 
30 (24.2) 27 (21.8) 67 (54.0) 0.487 0.002* 
⁑ Experience: (1-5); (6-10); (>10) years. 
*Significant (P-value <0.05) according to Fisher's Exact Test.  
GMP=Good manufactured practice. 
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Table 4: The attitude of participating physicians towards generic medicines 
  N (%) Fisher's Exact Test ( P-value) 
 Attitude item Disagree Neutral Agree Gender  Experience⁑ 
1 I wish to prescribe low cost medicines in my 
practice 
16 (12.9) 28 (22.6) 80 (64.5) 0.577 0.139 
2 I am concern about the therapeutic failures 
that are serious problems with some locally 
manufactured medicines 
13 (10.5) 29 (23.4) 82 (66.1) 0.207 0.279 
3 I am hesitant to prescribe low-cost brands in 
some specific therapeutic classes in my 
practice 
16 (12.9) 35 (28.2) 73 (58.9) 0.924 0.054 
4 I feel that the socioeconomic condition of my 
patient influences the prescription 
6 (4.8) 7 (5.6) 111 (89.5) 0.799 0.017* 
5 I am comfortable to prescribe products from 
all local manufacturers 
62 (50.0) 31 (25.0) 31 (25.0) 0.570 0.504 
6 I feel that my personal experience with 
medicines influence my prescribing decisions 
8 (6.5) 9 (7.3) 107 (86.3) 0.694 0.739 
7 I feel that patient’s demand of medicine 
influences my prescription 
28 (22.6) 22 (17.7) 74 (59.7) 0.614 0.037* 
8 I feel that medical representative is a good 
source of information for me 
52 (41.9) 29 (23.4) 43 (34.7) 0.828 0.532 
9 I feel that pharmaceutical companies’ 
premium offers (gifts) influence my 
prescribing behavior 
98 (79.0) 13 (10.5) 13 (10.5) 0.735 0.429 
10 I feel a lack of quality check in locally 
manufactured products 
15 (12.1) 33 (26.6) 76 (61.3) 0.960 0.825 
11 I am comfortable if the brand name medicine 
in prescription is changed by pharmacist 
80 (64.5) 20 (16.1) 24 (19.4) 0.970 0.059 
12 I offer my patients generic medicines 14 (11.3) 46 (37.1) 64 (51.6) 0.185 0.249 
   ⁑ Experience: (1-5); (6-10); (>10) years. 
    *Significant (P-value <0.05) according to Fisher's Exact Test.  
 
 
 
 
 
Figure 2: Perceptions and attitudes of physicians about locally manufactured medicines 
 
 
